XNAS · Healthcare · Medical Instruments & Supplies
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-04 | Q1 2026 | -0.24 | -0.27 | -12.50% | $401,000 | ❌ Miss | -0.82% | -4.74% | +24.76% |
| 2026-02-19 | Q4 2025 | -0.25 | -0.26 | -4.00% | $264,000 | ❌ Miss | -0.68% | -23.09% | -11.88% |
| 2025-11-05 |
| Q3 2025 |
| -0.31 |
| -0.29 |
| +6.45% |
| $86,000 |
| ✅ Beat |
| — |
| — |
| — |
| 2025-08-12 | Q2 2025 | -0.26 | -0.28 | -7.69% | $0 | ❌ Miss | +0.20% | +5.03% | +0.00% |
| 2025-03-27 | Q4 2024 | — | -0.17 | — | $0 | — | +6.00% | -7.22% | +14.62% |
| 2024-08-12 | Q2 2024 | — | -0.20 | — | $0 | — | +8.05% | +27.54% | +9.52% |
| 2024-05-07 | Q1 2024 | — | -0.15 | — | $0 | — | -9.21% | +1.18% | +91.38% |
| 2024-03-28 | Q4 2023 | — | -0.15 | — | $0 | — | — | — | — |
Showing last 8 quarters.